AP-HP and Université Paris Cité join the ID Cluster Board of Directors as founding members

“I am delighted to welcome Université Paris Cité and AP-HP, Assistance Publique – Hôpitaux de Paris, to our Board of Directors as founding members behind the creation of the biocluster in 2023. Alongside the eight current public and private administrators, and in particular the Hospices Civils de Lyon – HCL and Claude Bernard Lyon 1 University, AP-HP and UPC will bring their academic and clinical expertise and the various collaborative platforms in which they are involved to the fight against emerging infectious diseases and antimicrobial resistance. With their arrival, the composition of the ID Cluster board of directors perfectly reflects the need to strengthen academic and industrial collaborations at the national and European level, in a One Health dimension” said Prof. Bruno Lina, President of Infectious Diseases Cluster.

“In 2022, AP-HP committed to a project to establish a French biocluster dedicated to the fight against infectious diseases. We are therefore delighted to join its board of directors, backed by our leading infectious disease services and extensive technical biology facilities, particularly in immunology and bacteriology. We also have numerous research support structures and are involved in several national platforms developed as part of the national IED and CBRN (chemical, biological, radiological and nuclear) threats strategy (IReivac émergence, OPEN-ReMlE, etc.) and the PEPR Bioproduction program. Awarded the Institut Carnot label in 2019 for the quality of its research partnerships with industrial players, AP-HP firmly believes that its participation in ID Cluster will strengthen synergies between academic, hospital, and industrial players, and also contribute to the rapid implementation of innovative solutions to respond to emerging health crises,” explains Milan LAZAREVIC, Director of Clinical Research and Innovation at AP-HP.

“Université Paris Cité, an active member of IDCluster’s application for Bioclusters France 2030, is delighted to join its administrators. UPCité will bring its academic expertise in emerging infectious diseases and antibiotic resistance to bear through more than 10 joint research units in the Faculty of Health and the Faculty of Science. In particular, UPCité runs the Graduate School One Health – Emerging Infectious Diseases, which brings together the faculties of Health, Sciences, and Societies and Humanities of Université Paris Cité, the Institut de physique du globe de Paris, the Institut Pasteur Institute, and the National Veterinary School of Alfort. In addition, UPCité will enable ID Cluster to benefit from its links with the AP-HP for the Reference Health Establishment for Epidemic and Biological Risk, the national COREB mission, and the Safeguard Pandemic Preparedness Institute project. We are strongly committed to developing academic-private partnerships with the pharmaceutical industry to stimulate and accelerate transfer and innovation capabilities,” adds Odile LAUNAY, University Professor of Infectious and Tropical Diseases at Université Paris Cité.